Intelligence · Clinical Development
Pipeline search results
Programs matching “alzheimer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 141 pipeline programs matching "alzheimer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
NIO752B12201
Novartis Pharmaceuticals
Alzheimer’s Disease
1 trial -
NMRA-323511
Neumora Therapeutics
Alzheimer's Disease
1 trial -
SAM-315
Wyeth is now a wholly owned subsidiary of Pfizer
Alzheimer Disease
1 trial -
Safety for A Phase 1, Randomized, Double-B…
Lacuna Pharma Pty Ltd
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses and Food Effect of Leucettinib-21 in Healthy Male Subjects, followed by an open single dose of Leucettinib-21 in Down Syndrome individuals, and patients with Alzheimer’s disease
1 trial -
TAK-071
Takeda
Alzheimer Disease
1 trial -
TTP4000
vTv Therapeutics
Alzheimer's Disease
1 trial -
UECHUP-DON/23-5
Laboratorios Tillomed Spain S.L.U
Alzheimer's disease
1 trial -
UECHUP-MEM/25-6
Laboratorios Tillomed Spain S.L.U
Alzheimer’s disease
1 trial -
Velusetrag
Theravance Biopharma Ireland Umited
Alzheimer's Disease
1 trial -
[18F]APN-1607
The First People's Hospital of Lianyungang
Alzheimer Disease
1 trial -
high-fat diet group（AD16 20mg）
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Alzheimer Disease
1 trial -
sabirnetug (ACU193)
Acumen Pharmaceuticals
Alzheimer Disease
1 trial -
DONEPEZIL, DONEPEZIL
Pari Pharma GmbH
Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease
1 trial -
Lecanemab 10 mg/kg
The First People's Hospital of Lianyungang
Alzheimer s Disease
1 trial -
Rivastigmine
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
Rivastigmine transdermal patch
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
Blood ponction
MAIA Biotechnology
Alzheimer Blood Biomarkers
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Overnight polysomnography
COGNITION THERAPEUTICS INC
Alzheimer Disease, Early Onset
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
rivastigmine patch
Dong Wang
Alzheimer's Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.